DIRAS3 and thyroid gland carcinoma: Some studies have shown that the decrease in DIRAS3 expression is more prominent in younger patients with thyroid cancer, indicating the potential role of DIRAS3 in the aggressive behaviour of thyroid tumours in certain age groups [21,31].